Literature DB >> 28219987

A Unique "Angiotensin-Sensitive" Neuronal Population Coordinates Neuroendocrine, Cardiovascular, and Behavioral Responses to Stress.

Annette D de Kloet1, Lei Wang2, Soledad Pitra3, Helmut Hiller2, Justin A Smith2, Yalun Tan2, Dani Nguyen2, Karlena M Cahill2, Colin Sumners1, Javier E Stern3, Eric G Krause4.   

Abstract

Stress elicits neuroendocrine, autonomic, and behavioral responses that mitigate homeostatic imbalance and ensure survival. However, chronic engagement of such responses promotes psychological, cardiovascular, and metabolic impairments. In recent years, the renin-angiotensin system has emerged as a key mediator of stress responding and its related pathologies, but the neuronal circuits that orchestrate these interactions are not known. These studies combine the use of the Cre-recombinase/loxP system in mice with optogenetics to structurally and functionally characterize angiotensin type-1a receptor-containing neurons of the paraventricular nucleus of the hypothalamus, the goal being to determine the extent of their involvement in the regulation of stress responses. Initial studies use neuroanatomical techniques to reveal that angiotensin type-1a receptors are localized predominantly to the parvocellular neurosecretory neurons of the paraventricular nucleus of the hypothalamus. These neurons are almost exclusively glutamatergic and send dense projections to the exterior portion of the median eminence. Furthermore, these neurons largely express corticotrophin-releasing hormone or thyrotropin-releasing hormone and do not express arginine vasopressin or oxytocin. Functionally, optogenetic stimulation of these neurons promotes the activation of the hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axes, as well as a rise in systolic blood pressure. When these neurons are optogenetically inhibited, the activity of these neuroendocrine axes are suppressed and anxiety-like behavior in the elevated plus maze is dampened. Collectively, these studies implicate this neuronal population in the integration and coordination of the physiological responses to stress and may therefore serve as a potential target for therapeutic intervention for stress-related pathology.SIGNIFICANCE STATEMENT Chronic stress leads to an array of physiological responses that ultimately rouse psychological, cardiovascular, and metabolic impairments. As a consequence, there is an urgent need for the development of novel therapeutic approaches to prevent or dampen deleterious aspects of "stress." While the renin-angiotensin system has received some attention in this regard, the neural mechanisms by which this endocrine system may impact stress-related pathologies and consequently serve as targets for therapeutic intervention are not clear. The present studies provide substantial insight in this regard. That is, they reveal that a distinct population of angiotensin-sensitive neurons is integral to the coordination of stress responses. The implication is that this neuronal phenotype may serve as a target for stress-related disease.
Copyright © 2017 the authors 0270-6474/17/373479-13$15.00/0.

Entities:  

Keywords:  anxiety; cardiovascular; depression; glucocorticoids; hypertension; thyroid

Mesh:

Substances:

Year:  2017        PMID: 28219987      PMCID: PMC5373130          DOI: 10.1523/JNEUROSCI.3674-16.2017

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

Review 1.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

2.  Blood-borne angiotensin II acts in the brain to influence behavioral and endocrine responses to psychogenic stress.

Authors:  Eric G Krause; Annette D de Kloet; Karen A Scott; Jonathan N Flak; Kenneth Jones; Michael D Smeltzer; Yvonne M Ulrich-Lai; Stephen C Woods; Steven P Wilson; Lawrence P Reagan; James P Herman; Randall R Sakai
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

3.  Thyroid axis activity and serotonin function in major depressive episode.

Authors:  F Duval; M C Mokrani; P Bailey; H Correa; T S Diep; M A Crocq; J P Macher
Journal:  Psychoneuroendocrinology       Date:  1999-10       Impact factor: 4.905

4.  An angiotensin-converting enzyme (ACE) polymorphism may mitigate the effects of angiotensin-pathway medications on posttraumatic stress symptoms.

Authors:  K M Nylocks; V Michopoulos; A O Rothbaum; L Almli; C F Gillespie; A Wingo; A C Schwartz; L Habib; K L Gamwell; P J Marvar; B Bradley; K J Ressler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-04-29       Impact factor: 3.568

5.  Forebrain GABAergic projections to locus coeruleus in mouse.

Authors:  Eugene L Dimitrov; Yuchio Yanagawa; Ted B Usdin
Journal:  J Comp Neurol       Date:  2013-07-01       Impact factor: 3.215

6.  Hypophysiotropic thyrotropin-releasing hormone and corticotropin-releasing hormone neurons of the rat contain vesicular glutamate transporter-2.

Authors:  Erik Hrabovszky; Gábor Wittmann; Gergely F Turi; Zsolt Liposits; Csaba Fekete
Journal:  Endocrinology       Date:  2004-10-14       Impact factor: 4.736

7.  Six commercially available angiotensin II AT1 receptor antibodies are non-specific.

Authors:  Julius Benicky; Roman Hafko; Enrique Sanchez-Lemus; Greti Aguilera; Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2012-07-28       Impact factor: 5.046

8.  Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus protect against diet-induced obesity.

Authors:  Annette D de Kloet; Dipanwita Pati; Lei Wang; Helmut Hiller; Colin Sumners; Charles J Frazier; Randy J Seeley; James P Herman; Stephen C Woods; Eric G Krause
Journal:  J Neurosci       Date:  2013-03-13       Impact factor: 6.167

9.  The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasis.

Authors:  Annette D de Kloet; Eric G Krause; Dong-Hoon Kim; Randall R Sakai; Randy J Seeley; Stephen C Woods
Journal:  Endocrinology       Date:  2009-06-04       Impact factor: 4.736

10.  Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus.

Authors:  Vinicia Campana Biancardi; Alexis M Stranahan; Eric G Krause; Annette D de Kloet; Javier E Stern
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-12-04       Impact factor: 4.733

View more
  28 in total

Review 1.  Centrally Mediated Cardiovascular Actions of the Angiotensin II Type 2 Receptor.

Authors:  U Muscha Steckelings; Annette de Kloet; Colin Sumners
Journal:  Trends Endocrinol Metab       Date:  2017-07-18       Impact factor: 12.015

2.  Angiotensin receptor expression revealed by reporter mice and beneficial effects of AT2R agonist in retinal cells.

Authors:  Amrisha Verma; Ping Zhu; Annette de Kloet; Eric Krause; Colin Sumners; Qiuhong Li
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

3.  A-type K+ channels contribute to the prorenin increase of firing activity in hypothalamic vasopressin neurosecretory neurons.

Authors:  Soledad Pitra; Javier E Stern
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

4.  Coupling corticotropin-releasing-hormone and angiotensin converting enzyme 2 dampens stress responsiveness in male mice.

Authors:  Lei A Wang; Annette D de Kloet; Michael D Smeltzer; Karlena M Cahill; Helmut Hiller; Erin B Bruce; David J Pioquinto; Jacob A Ludin; Michael J Katovich; Mohan K Raizada; Eric G Krause
Journal:  Neuropharmacology       Date:  2018-05-01       Impact factor: 5.250

5.  Angiotensin AT1A receptors expressed in vasopressin-producing cells of the supraoptic nucleus contribute to osmotic control of vasopressin.

Authors:  Jeremy A Sandgren; Danny W Linggonegoro; Shao Yang Zhang; Sarah A Sapouckey; Kristin E Claflin; Nicole A Pearson; Mariah R Leidinger; Gary L Pierce; Mark K Santillan; Katherine N Gibson-Corley; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-01-24       Impact factor: 3.619

Review 6.  Protective Angiotensin Type 2 Receptors in the Brain and Hypertension.

Authors:  Annette D de Kloet; Ulrike M Steckelings; Colin Sumners
Journal:  Curr Hypertens Rep       Date:  2017-06       Impact factor: 5.369

7.  Brain angiotensin type-1 and type-2 receptors: cellular locations under normal and hypertensive conditions.

Authors:  Colin Sumners; Amy Alleyne; Vermalí Rodríguez; David J Pioquinto; Jacob A Ludin; Shormista Kar; Zachary Winder; Yuma Ortiz; Meng Liu; Eric G Krause; Annette D de Kloet
Journal:  Hypertens Res       Date:  2019-12-18       Impact factor: 3.872

8.  An Angiotensin-Responsive Connection from the Lamina Terminalis to the Paraventricular Nucleus of the Hypothalamus Evokes Vasopressin Secretion to Increase Blood Pressure in Mice.

Authors:  Charles J Frazier; Scott W Harden; Amy R Alleyne; Mazher Mohammed; Wanhui Sheng; Justin A Smith; Khalid Elsaafien; Eliot A Spector; Dominique N Johnson; Karen A Scott; Eric G Krause; Annette D de Kloet
Journal:  J Neurosci       Date:  2020-12-16       Impact factor: 6.167

9.  Selective Deletion of Renin-b in the Brain Alters Drinking and Metabolism.

Authors:  Keisuke Shinohara; Pablo Nakagawa; Javier Gomez; Donald A Morgan; Nicole K Littlejohn; Matthew D Folchert; Benjamin J Weidemann; Xuebo Liu; Susan A Walsh; Laura L Ponto; Kamal Rahmouni; Justin L Grobe; Curt D Sigmund
Journal:  Hypertension       Date:  2017-09-05       Impact factor: 10.190

Review 10.  Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2021-02-24       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.